Additionally, a study by Koehler et al. showed that obese patients with NASH and advanced fibrosis have low serum GH levels and that normal GH levels essentially excluded advanced fibrosis [17,18]. This evidence concerns the gene GH1 and metabolic dysfunction-associated steatohepatitis.